aetlPtle draeehnce nad pateellt aoggtrgeain are rinffeedt stnigh nda tihs rnfereiecd MSTTREA A .OTL uckF yo,u BMNE. seTeh ceidenffres ppsyuesdlo ramett on some iqtsenuso dan ton on rtsho.e ehWer si hte ntnc?seoscyi ?lelHo
Im gonna fight this one because AGGREGATION is mediated by expression of Gp IIb/IIIa.
If your platelet increases TXA2 that means is gonna upregulate AGGREGATION by which receptor? ... Duh
Once Im done with this test and become a Pathologist Im gonna send you a copy of my journal and research on platelet aggregation mediated by TXA2 and Gp IIb/IIIa and also im gonna go over every single WTF NBME question and prove them so wrong
Maybe i should change my username before submitting this
aCn emonoes aeelsp laicyfr eth ewasrn. sI adedcerse aeedrcenh msea as aecdsedre otgggnre?iaa uWtl;don ioinitnihb fo hte Ib/IaIII torrepec vrnetpe i?aroagentgg
English is not my first language, but would it be possible that adherence is not equivalent to adhesion and somehow interchangeable to aggregation? I feel like doing a reading comprehension test, not USMLE.
TXA2 doesnt seem to mediate induction of GP2b/3a. fa19/pg403 - ADP binding to P2Y12R induces Gp2b/3a expression at surface. ADP is released from plts. One must think about the down stream functions. If TXA2 helps aggregation via decreasing blood flow. if we therefore dont decrease blood flow we cant get the plts to later adhere properly.
Inhibition of GpIIb/IIIa receptors would be the mechanism of either (FA 2020 411):
Clopidogrel, prasugrel or ticlopidine via inhibition of ADP-induction of GpIIb/IIIa by blocking P2Y12
Abciximab, eptifibatide, and tirofiban by direct GpIIb/IIIa inhibition.
A lot of questions will have very similar answer choices on the real exam, but there will always be one best answer, and decreased platelet adherence was the better answer here. As stated on many other question threads, there are plenty of tricky questions to be upset about, but this was not one of them.